HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shigeki Katoh Selected Research

Pulmonary Eosinophilia (Eosinophilic Pneumonia)

9/2020Elevated levels of periostin and TGF-β1 in the bronchoalveolar lavage fluid of patients with idiopathic eosinophilic pneumonia.
12/2017Possible Role of IL-25 in Eosinophilic Lung Inflammation in Patients with Chronic Eosinophilic Pneumonia.
1/2012Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.
7/2005Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia.
5/2003A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia.
3/2003Critical role of IL-5 in antigen-induced pulmonary eosinophilia, but not in lymphocyte activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shigeki Katoh Research Topics

Disease

19Inflammation (Inflammations)
11/2022 - 03/2003
10Asthma (Bronchial Asthma)
11/2022 - 07/2007
8Respiratory Hypersensitivity
11/2022 - 03/2003
6Pulmonary Eosinophilia (Eosinophilic Pneumonia)
09/2020 - 03/2003
3Idiopathic Pulmonary Fibrosis
09/2020 - 04/2013
3Pneumonia (Pneumonitis)
12/2017 - 02/2010
2Sarcoidosis (Schaumann Disease)
09/2020 - 12/2017
2Chronic Obstructive Pulmonary Disease (COPD)
10/2018 - 01/2007
1Lung Diseases (Lung Disease)
09/2020
1Fibrosis (Cirrhosis)
09/2020
1Atopic Dermatitis (Atopic Eczema)
09/2020
1Carrington syndrome
12/2017
1Immune System Diseases (Immune Disorders)
01/2017
1Infections
01/2014
1Human Influenza (Influenza)
01/2014
1Hypersensitivity (Allergy)
10/2013
1Idiopathic Interstitial Pneumonias
04/2013
1Vascular Diseases (Vascular Disease)
04/2013
1Cough
03/2011
1Atherosclerosis
02/2009
1Neoplasms (Cancer)
09/2008
1Osteoarthritis
12/2007
1Rheumatoid Arthritis
12/2007
1Paragonimiasis
07/2004
1Eosinophilia
03/2003

Drug/Important Bio-Agent (IBA)

10AntigensIBA
01/2021 - 03/2003
5AllergensIBA
11/2022 - 07/2007
5EnzymesIBA
09/2020 - 01/2012
5ImmunosorbentsIBA
09/2020 - 01/2012
4Interleukin-5 (Interleukin 5)IBA
12/2021 - 03/2003
4InterleukinsIBA
12/2021 - 03/2003
4CytokinesIBA
01/2021 - 01/2012
3Immunoglobulin E (IgE)IBA
11/2022 - 07/2017
2Interleukin-13IBA
12/2021 - 09/2020
2Interleukin-33IBA
12/2021 - 12/2017
2PeriostinIBA
09/2020 - 10/2018
2Biomarkers (Surrogate Marker)IBA
10/2018 - 01/2014
2Interleukin-17 (Interleukin 17)IBA
10/2018 - 02/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2013 - 01/2007
2Interleukin-5 Receptors (Interleukin 5 Receptor)IBA
10/2013 - 03/2003
2Chemotactic FactorsIBA
01/2012 - 01/2010
2Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2011 - 03/2011
2LigandsIBA
09/2008 - 07/2005
1Hyaluronic Acid (Hyaluronan)IBA
11/2022
1Neuraminidase (Sialidase)IBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2020
1N 30IBA
10/2018
1Double-Stranded RNA (RNA, Double Stranded)IBA
12/2013
1InterferonsIBA
12/2013
1Chemokine CCL5IBA
12/2013
1ChemokinesIBA
10/2013
1LeukotrienesIBA
10/2013
1Formoterol Fumarate (Oxis)FDA Link
09/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2013
1Budesonide (Pulmicort)FDA LinkGeneric
09/2013
1CollagenIBA
04/2013
1Therapeutic UsesIBA
01/2012
1Interleukin-1 (Interleukin 1)IBA
02/2010
1Interleukin-6 (Interleukin 6)IBA
02/2010
1Apolipoproteins E (ApoE)IBA
02/2009
1Integrin alpha1IBA
09/2008
1Integrin alpha2IBA
09/2008
1Galectins (Galectin)IBA
12/2007
1Proteins (Proteins, Gene)FDA Link
07/2007
1Biological ProductsIBA
07/2007
1Interleukin-8 (Interleukin 8)IBA
01/2007
1Theophylline (Theon)FDA LinkGeneric
01/2007
1Chemokine CCL17IBA
07/2004

Therapy/Procedure

2Intranasal Administration
12/2021 - 01/2012
1Intraperitoneal Injections
01/2021
1Immunotherapy
07/2017
1Therapeutics
12/2013